• 1
    Blaser MJ. Epidemiology and pathophysiology of Campylobacter pylori infections. Rev Infect Dis 1990; 129: 4459.
  • 2
    Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9: 339.
  • 3
    Malaty HM, Kim JG, Kim SD, Graham DY. Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socio-economic status despite a uniformly high prevalence of adults. Am J Epidemiol 1996; 143: 25762.
  • 4
    Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990; 3: 33544.
  • 5
    Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999; 38: 1326.
  • 6
    Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 1995; 79: 4759.
  • 7
    Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989; 27: 232830.
  • 8
    Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93: 2097101.
    Direct Link:
  • 9
    Coconnier M-H, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 457380.
  • 10
    Dent JC, Nulty CAM. Evaluation of a new selective medium for Campylobacter pylori. Eur J Clin Microbiol Infect Dis 1988; 7: 5558.
  • 11
    Sambrook J, Fritsch EF, Maniatas T. Preparation of reagents and buffers used in molecular cloning. In: SambrookJ, FritschE, ManiatasT, eds. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
  • 12
    Ferrero RL, Cussac V, Courcoux P, Labigne A. Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol 1992; 174: 42127.
  • 13
    Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of traveller's diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 536.
  • 14
    Shore EG, Dean AG, Holik KJ, Davis BR. Enterotoxin producing Escherichia coli diarrhoeal disease in adult travellers: a prospective study. J Infect Dis 1974; 129: 57782.
  • 15
    Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30: 5460.
  • 16
    Gordon D, Macrae J, Wheater DM. A lactobacillus preparation for use with antibiotics. Lancet 1957; ii: 899901.
  • 17
    Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 579.
  • 18
    Michetti P, Dorta G, Wiesel PH, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection. Digestion 1999; 60: 2039.
  • 19
    Kabir AMA, Aiba Y, Takagi A, Kamiya S, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 4955.
  • 20
    Lorca GL, Wadstrom T, Font de Valdez GF, Ljungh A. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001; 42: 3944.
  • 21
    Marchand J, Vandenplas Y. Micro-organisms administered in the benefit of the host: myths and facts. Eur J Gastroenterol Hepatol 2000; 12: 107788.
  • 22
    Wendakoon CN, Fedio W, Macleod A, Ozimek L. In vitro inhibition of Helicobacter pylori by dairy starter cultures . Milchwissenschaft 1998; 53: 499502.
  • 23
    Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987; 70: 112.
  • 24
    Felley CP, Corthésy-Theulaz I, Rivero J-LB, et al. Favourable effects of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13: 259.
  • 25
    Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001; 47: 70910.
  • 26
    Goddard AF, Logan RPH. Review article: urea breath tests for detecting Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 6419.
  • 27
    De Boer WA. Diagnosis of Helicobacter pylori infection. Review of diagnostic techniques and recommendations for their use in different clinical settings. Scand J Gastroenterol 1997; 32: 3542.
  • 28
    Sheu BS, Lee SC, Yang HB, Lin XZ. Quantitative result of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology 1999; 46: 205762.
  • 29
    Ellenrieder V, Glasbrenner B, Stoffels C, et al. Qualitative and semi-quantitative value of a modified 13C-urea breath test for identification of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1997; 9: 10859.
  • 30
    Hilker E, Domschke W, Stoll R. 13C-urea breath test for detection of Helicobacter pylori and its correlation with endoscopic and histologic findings. J Physiol Pharmacol 1996; 47: 7990.
  • 31
    Wendakoon CN, Thomson ABR, Ozimek L. Lack of therapeutic effect of a specially designed yoghurt for the eradication of Helicobacter pylori infection. Digestion 2002; 65: 1620.
  • 32
    Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 16259.
  • 33
    Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 1639.